Mechanistically, POLR2J4 knockdown reduced the expression of drug resistance genes (ABCB1, ABCC1, BCL2), decreased serum levels of IL-6 and TGF-β1, and downregulated TGF-β1 and PD-L1 in tumor tissues, highlighting its role in establishing an immunosuppressive, drug-resistant microenvironment. This evidence concerns the gene POLR2J4 and neoplasm.